Here are five things to know:
1. This cut is part of an effort to remove $1 billion in annual costs in the business that makes sterilization equipment and surgical tools.
2. The eliminated positions represent 2.5 percent of Johnson & Johnson’s global workforce and up to 6 percent of its medical device segment.
3. Johnson & Johnson’s medical device sales have been struggling lately, with sales slipping 2.9 percent in the first nine months of the year and 2.4 percent in the United States.
4. The moves relate to Johnson & Johnson’s orthopedic, surgery and cardiovascular businesses.
5. The company said the restructuring won’t affect its consumer medical devices businesses, vision care and diabetes care businesses.
More articles on devices and implants:
SeaSpine, K2M, Smith & Nephew & more: 19 key notes
DeGen Medical launches Hyper-C Anterior Cervical Plate System: 4 key notes
Medical Compression Systems seeks buyer: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
